Ginsenoside Rb1 for myocardial ischemia/reperfusion injury: Preclinical evidence and possible mechanisms

65Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ginseng is an important herbal drug that has been used worldwide for many years. Ginsenoside Rb1 (G-Rb1), the major pharmacological extract from ginseng, possesses a variety of biological activities in the cardiovascular systems. Here, we conducted a preclinical systematic review to investigate the efficacy of G-Rb1 for animal models of myocardial ischemia/reperfusion injury and its possible mechanisms. Ten studies involving 211 animals were identified by searching 6 databases from inception to May 2017. The methodological quality was assessed by using the CAMARADES 10-item checklist. All the data were analyzed using RevMan 5.3 software. As a result, the score of study quality ranged from 3 to 7 points. Meta-analyses showed that G-Rb1 can significantly decrease the myocardial infarct size and cardiac enzymes (including lactate dehydrogenase, creatine kinase, and creatine kinase-MB) when compared with control group (P<0.01). Significant decrease in cardiac troponin T and improvement in the degree of ST-segment depression were reported in one study (P<0.05). Additionally, the possible mechanisms of G-Rb1 for myocardial infarction are antioxidant, anti-inflammatory, antiapoptosis, promoting angiogenesis and improving the circulation. Thus, G-Rb1 is a potential cardioprotective candidate for further clinical trials of myocardial infarction.

References Powered by Scopus

Heart disease and stroke statistics-2015 update : A report from the American Heart Association

6363Citations
N/AReaders
Get full text

Improving bioscience research reporting: The arrive guidelines for reporting animal research

5691Citations
N/AReaders
Get full text

Myocardial reperfusion injury

3256Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I

139Citations
N/AReaders
Get full text

Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy

81Citations
N/AReaders
Get full text

Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway

77Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zheng, Q., Bao, X. Y., Zhu, P. C., Tong, Q., Zheng, G. Q., & Wang, Y. (2017). Ginsenoside Rb1 for myocardial ischemia/reperfusion injury: Preclinical evidence and possible mechanisms. Oxidative Medicine and Cellular Longevity. Hindawi Limited. https://doi.org/10.1155/2017/6313625

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

57%

Researcher 3

21%

Lecturer / Post doc 2

14%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

37%

Biochemistry, Genetics and Molecular Bi... 6

32%

Pharmacology, Toxicology and Pharmaceut... 3

16%

Neuroscience 3

16%

Save time finding and organizing research with Mendeley

Sign up for free